Downloads.hindawi.com

4.15.3 With pressure growing to achieve more demanding development milestones quickly, while controlling R&D expenses and meeting shareholder expectations, biotechs are increasingly finding the capability and expertise of CROs invaluable, not just in conducting their R&D programmes but in designing and managing their compound’s drug development. ................
................